Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 18.80 Delayed Data As of May 26 |  +0.60 / +3.30%Today’s Change | 17.90 Today|||52-Week Range 36.83 | -45.98% Year-to-Date |
| Alpha & Omega Semiconductor, AMAG Pharmaceuticals and Trade Desk highlighted as Zacks... May 15 / Zacks.com - Paid Partner Content | Bear of the Day: AMAG Pharmaceuticals (AMAG) May 15 / Zacks.com - Paid Partner Content |
| Previous close | 18.20 |
| Today’s open | 18.30 |
| Day’s range | 18.00 - 18.95 |
| Volume | 1,229,442 |
| Average volume (3 months) | 1,169,799 |
| Market cap | $658.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -107.53% |
| Earnings growth (this year) | -9.98% |
| Earnings growth (next 5 years) | +4.40% |
| Revenue growth (last year) | +27.21% |
| P/E ratio | NM |
| Price/Sales | 2.25 |
| Price/Book | 0.69 |
| Today’s change | Today’s % change | |
|---|---|---|
| EDITEditas Medicine Inc | -0.69 | -4.23% |
| JNCEJounce Therapeutics ... | -1.50 | -6.62% |
| RTRXRetrophin Inc | -0.47 | -2.77% |
| CRSPCRISPR Therapeutics ... | -0.34 | -2.21% |
| Next reporting date | July 27, 2017 |
| EPS forecast (this quarter) | $1.41 |
| Annual revenue (last year) | $532.1M |
| Annual profit (last year) | -$2.5M |
| Net profit margin | -0.47% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
Chief Financial Officer, Treasurer & Senior VP Edward H. Myles |
Corporate headquarters Waltham, Massachusetts |
